nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—CYP3A4—Rivastigmine—Alzheimer's disease	0.182	0.432	CbGbCtD
Topotecan—CYP3A4—Donepezil—Alzheimer's disease	0.145	0.345	CbGbCtD
Topotecan—CYP3A4—Galantamine—Alzheimer's disease	0.0936	0.223	CbGbCtD
Topotecan—Irinotecan—ACHE—Alzheimer's disease	0.00943	0.63	CrCbGaD
Topotecan—Irinotecan—BCHE—Alzheimer's disease	0.00555	0.37	CrCbGaD
Topotecan—TOP1MT—nervous system—Alzheimer's disease	0.00491	0.133	CbGeAlD
Topotecan—TOP1MT—central nervous system—Alzheimer's disease	0.00473	0.128	CbGeAlD
Topotecan—TOP1MT—cerebellum—Alzheimer's disease	0.00462	0.125	CbGeAlD
Topotecan—TOP1—telencephalon—Alzheimer's disease	0.00439	0.119	CbGeAlD
Topotecan—TOP1MT—brain—Alzheimer's disease	0.00376	0.101	CbGeAlD
Topotecan—Lethargy—Galantamine—Alzheimer's disease	0.00338	0.00743	CcSEcCtD
Topotecan—Bone pain—Memantine—Alzheimer's disease	0.00336	0.00737	CcSEcCtD
Topotecan—Bone pain—Rivastigmine—Alzheimer's disease	0.00328	0.00721	CcSEcCtD
Topotecan—Respiratory failure—Memantine—Alzheimer's disease	0.00327	0.00719	CcSEcCtD
Topotecan—Pulmonary embolism—Memantine—Alzheimer's disease	0.00322	0.00706	CcSEcCtD
Topotecan—Respiratory failure—Rivastigmine—Alzheimer's disease	0.0032	0.00703	CcSEcCtD
Topotecan—Pulmonary embolism—Rivastigmine—Alzheimer's disease	0.00315	0.00691	CcSEcCtD
Topotecan—Colitis—Memantine—Alzheimer's disease	0.00309	0.00678	CcSEcCtD
Topotecan—Sepsis—Donepezil—Alzheimer's disease	0.00307	0.00675	CcSEcCtD
Topotecan—Colitis—Rivastigmine—Alzheimer's disease	0.00302	0.00663	CcSEcCtD
Topotecan—Neuropathy—Memantine—Alzheimer's disease	0.00302	0.00663	CcSEcCtD
Topotecan—Ear pain—Donepezil—Alzheimer's disease	0.00301	0.00661	CcSEcCtD
Topotecan—Neuropathy—Rivastigmine—Alzheimer's disease	0.00295	0.00648	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—APP—Alzheimer's disease	0.00295	0.0411	CbGpPWpGaD
Topotecan—Neoplasm—Memantine—Alzheimer's disease	0.00291	0.00638	CcSEcCtD
Topotecan—Rash maculo-papular—Rivastigmine—Alzheimer's disease	0.00286	0.00628	CcSEcCtD
Topotecan—Neoplasm—Rivastigmine—Alzheimer's disease	0.00284	0.00624	CcSEcCtD
Topotecan—Sepsis—Memantine—Alzheimer's disease	0.00279	0.00613	CcSEcCtD
Topotecan—Ear pain—Memantine—Alzheimer's disease	0.00274	0.00601	CcSEcCtD
Topotecan—Sepsis—Rivastigmine—Alzheimer's disease	0.00273	0.00599	CcSEcCtD
Topotecan—Dermatitis bullous—Donepezil—Alzheimer's disease	0.00269	0.0059	CcSEcCtD
Topotecan—Ear pain—Rivastigmine—Alzheimer's disease	0.00268	0.00588	CcSEcCtD
Topotecan—Pneumonia—Galantamine—Alzheimer's disease	0.00257	0.00564	CcSEcCtD
Topotecan—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.00251	0.0055	CcSEcCtD
Topotecan—Dermatitis bullous—Memantine—Alzheimer's disease	0.00244	0.00536	CcSEcCtD
Topotecan—TOP1—cerebellum—Alzheimer's disease	0.00244	0.0659	CbGeAlD
Topotecan—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00242	0.00531	CcSEcCtD
Topotecan—Epistaxis—Galantamine—Alzheimer's disease	0.00241	0.00529	CcSEcCtD
Topotecan—Dermatitis bullous—Rivastigmine—Alzheimer's disease	0.00239	0.00524	CcSEcCtD
Topotecan—Lethargy—Memantine—Alzheimer's disease	0.00238	0.00523	CcSEcCtD
Topotecan—Cramp muscle—Donepezil—Alzheimer's disease	0.00231	0.00508	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.00231	0.00508	CcSEcCtD
Topotecan—Haemoglobin—Galantamine—Alzheimer's disease	0.00231	0.00506	CcSEcCtD
Topotecan—Rhinitis—Galantamine—Alzheimer's disease	0.0023	0.00505	CcSEcCtD
Topotecan—Haemorrhage—Galantamine—Alzheimer's disease	0.00229	0.00504	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.00227	0.00498	CcSEcCtD
Topotecan—Cardiac arrest—Memantine—Alzheimer's disease	0.00222	0.00487	CcSEcCtD
Topotecan—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.00217	0.00477	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—BAX—Alzheimer's disease	0.0021	0.0293	CbGpPWpGaD
Topotecan—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.0021	0.00461	CcSEcCtD
Topotecan—Angiopathy—Galantamine—Alzheimer's disease	0.00208	0.00457	CcSEcCtD
Topotecan—Immune system disorder—Galantamine—Alzheimer's disease	0.00207	0.00455	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.00206	0.00452	CcSEcCtD
Topotecan—Cramp muscle—Rivastigmine—Alzheimer's disease	0.00206	0.00451	CcSEcCtD
Topotecan—Weight increased—Donepezil—Alzheimer's disease	0.00202	0.00444	CcSEcCtD
Topotecan—Malnutrition—Galantamine—Alzheimer's disease	0.002	0.00439	CcSEcCtD
Topotecan—Pneumonia—Donepezil—Alzheimer's disease	0.00199	0.00437	CcSEcCtD
Topotecan—TOP1—brain—Alzheimer's disease	0.00198	0.0535	CbGeAlD
Topotecan—Infestation—Donepezil—Alzheimer's disease	0.00198	0.00435	CcSEcCtD
Topotecan—Infestation NOS—Donepezil—Alzheimer's disease	0.00198	0.00435	CcSEcCtD
Topotecan—Back pain—Galantamine—Alzheimer's disease	0.00193	0.00424	CcSEcCtD
Topotecan—Muscle spasms—Galantamine—Alzheimer's disease	0.00192	0.00422	CcSEcCtD
Topotecan—Pancytopenia—Memantine—Alzheimer's disease	0.00192	0.00421	CcSEcCtD
Topotecan—Sweating—Donepezil—Alzheimer's disease	0.0019	0.00417	CcSEcCtD
Topotecan—Neutropenia—Memantine—Alzheimer's disease	0.00189	0.00414	CcSEcCtD
Topotecan—Epistaxis—Donepezil—Alzheimer's disease	0.00187	0.0041	CcSEcCtD
Topotecan—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00185	0.00407	CcSEcCtD
Topotecan—Anaemia—Galantamine—Alzheimer's disease	0.00185	0.00405	CcSEcCtD
Topotecan—Weight increased—Memantine—Alzheimer's disease	0.00184	0.00403	CcSEcCtD
Topotecan—Pneumonia—Memantine—Alzheimer's disease	0.00181	0.00397	CcSEcCtD
Topotecan—Malaise—Galantamine—Alzheimer's disease	0.0018	0.00395	CcSEcCtD
Topotecan—Infestation NOS—Memantine—Alzheimer's disease	0.0018	0.00395	CcSEcCtD
Topotecan—Infestation—Memantine—Alzheimer's disease	0.0018	0.00395	CcSEcCtD
Topotecan—Weight increased—Rivastigmine—Alzheimer's disease	0.0018	0.00394	CcSEcCtD
Topotecan—Haemoglobin—Donepezil—Alzheimer's disease	0.00179	0.00392	CcSEcCtD
Topotecan—Rhinitis—Donepezil—Alzheimer's disease	0.00178	0.00391	CcSEcCtD
Topotecan—Haemorrhage—Donepezil—Alzheimer's disease	0.00178	0.0039	CcSEcCtD
Topotecan—Pneumonia—Rivastigmine—Alzheimer's disease	0.00177	0.00389	CcSEcCtD
Topotecan—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00177	0.00388	CcSEcCtD
Topotecan—Pharyngitis—Donepezil—Alzheimer's disease	0.00176	0.00387	CcSEcCtD
Topotecan—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00176	0.00387	CcSEcCtD
Topotecan—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00176	0.00386	CcSEcCtD
Topotecan—Infestation—Rivastigmine—Alzheimer's disease	0.00176	0.00386	CcSEcCtD
Topotecan—ABCB1—ABC-family proteins mediated transport—ABCA7—Alzheimer's disease	0.00175	0.0244	CbGpPWpGaD
Topotecan—Cough—Galantamine—Alzheimer's disease	0.00174	0.00383	CcSEcCtD
Topotecan—ABCG2—Irinotecan Pathway—BCHE—Alzheimer's disease	0.00173	0.024	CbGpPWpGaD
Topotecan—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.00172	0.00379	CcSEcCtD
Topotecan—Hepatobiliary disease—Memantine—Alzheimer's disease	0.0017	0.00373	CcSEcCtD
Topotecan—Myalgia—Galantamine—Alzheimer's disease	0.0017	0.00373	CcSEcCtD
Topotecan—Chest pain—Galantamine—Alzheimer's disease	0.0017	0.00373	CcSEcCtD
Topotecan—Arthralgia—Galantamine—Alzheimer's disease	0.0017	0.00373	CcSEcCtD
Topotecan—Epistaxis—Memantine—Alzheimer's disease	0.0017	0.00372	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00169	0.00371	CcSEcCtD
Topotecan—Sweating—Rivastigmine—Alzheimer's disease	0.00169	0.0037	CcSEcCtD
Topotecan—Discomfort—Galantamine—Alzheimer's disease	0.00168	0.00369	CcSEcCtD
Topotecan—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00166	0.00365	CcSEcCtD
Topotecan—Epistaxis—Rivastigmine—Alzheimer's disease	0.00166	0.00364	CcSEcCtD
Topotecan—Haemoglobin—Memantine—Alzheimer's disease	0.00162	0.00356	CcSEcCtD
Topotecan—Rhinitis—Memantine—Alzheimer's disease	0.00162	0.00355	CcSEcCtD
Topotecan—Haemorrhage—Memantine—Alzheimer's disease	0.00161	0.00354	CcSEcCtD
Topotecan—Hypoaesthesia—Memantine—Alzheimer's disease	0.00161	0.00353	CcSEcCtD
Topotecan—Pharyngitis—Memantine—Alzheimer's disease	0.0016	0.00352	CcSEcCtD
Topotecan—Nervous system disorder—Galantamine—Alzheimer's disease	0.0016	0.00351	CcSEcCtD
Topotecan—Thrombocytopenia—Galantamine—Alzheimer's disease	0.0016	0.0035	CcSEcCtD
Topotecan—Chills—Donepezil—Alzheimer's disease	0.0016	0.0035	CcSEcCtD
Topotecan—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00159	0.00349	CcSEcCtD
Topotecan—Rhinitis—Rivastigmine—Alzheimer's disease	0.00158	0.00348	CcSEcCtD
Topotecan—Skin disorder—Galantamine—Alzheimer's disease	0.00158	0.00348	CcSEcCtD
Topotecan—ABCB1—blood vessel—Alzheimer's disease	0.00158	0.0428	CbGeAlD
Topotecan—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00158	0.00347	CcSEcCtD
Topotecan—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00158	0.00346	CcSEcCtD
Topotecan—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00157	0.00345	CcSEcCtD
Topotecan—Alopecia—Donepezil—Alzheimer's disease	0.00157	0.00345	CcSEcCtD
Topotecan—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00157	0.00344	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.00156	0.0217	CbGpPWpGaD
Topotecan—ABCG2—telencephalon—Alzheimer's disease	0.00156	0.0421	CbGeAlD
Topotecan—Anorexia—Galantamine—Alzheimer's disease	0.00155	0.00341	CcSEcCtD
Topotecan—Malnutrition—Donepezil—Alzheimer's disease	0.00155	0.0034	CcSEcCtD
Topotecan—ABCB1—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.00154	0.0214	CbGpPWpGaD
Topotecan—Back pain—Donepezil—Alzheimer's disease	0.0015	0.00329	CcSEcCtD
Topotecan—Muscle spasms—Donepezil—Alzheimer's disease	0.00149	0.00327	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00149	0.00326	CcSEcCtD
Topotecan—Angiopathy—Memantine—Alzheimer's disease	0.00146	0.00322	CcSEcCtD
Topotecan—Paraesthesia—Galantamine—Alzheimer's disease	0.00146	0.00321	CcSEcCtD
Topotecan—Immune system disorder—Memantine—Alzheimer's disease	0.00146	0.0032	CcSEcCtD
Topotecan—Mediastinal disorder—Memantine—Alzheimer's disease	0.00146	0.00319	CcSEcCtD
Topotecan—Chills—Memantine—Alzheimer's disease	0.00145	0.00318	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.00145	0.0201	CbGpPWpGaD
Topotecan—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00144	0.00315	CcSEcCtD
Topotecan—Dyspepsia—Galantamine—Alzheimer's disease	0.00143	0.00315	CcSEcCtD
Topotecan—Angiopathy—Rivastigmine—Alzheimer's disease	0.00143	0.00315	CcSEcCtD
Topotecan—Anaemia—Donepezil—Alzheimer's disease	0.00143	0.00314	CcSEcCtD
Topotecan—Alopecia—Memantine—Alzheimer's disease	0.00143	0.00313	CcSEcCtD
Topotecan—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00142	0.00313	CcSEcCtD
Topotecan—Chills—Rivastigmine—Alzheimer's disease	0.00142	0.00311	CcSEcCtD
Topotecan—Decreased appetite—Galantamine—Alzheimer's disease	0.00142	0.00311	CcSEcCtD
Topotecan—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00141	0.00309	CcSEcCtD
Topotecan—Malnutrition—Memantine—Alzheimer's disease	0.00141	0.00309	CcSEcCtD
Topotecan—Fatigue—Galantamine—Alzheimer's disease	0.00141	0.00309	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.0014	0.0195	CbGpPWpGaD
Topotecan—Malaise—Donepezil—Alzheimer's disease	0.0014	0.00306	CcSEcCtD
Topotecan—Alopecia—Rivastigmine—Alzheimer's disease	0.0014	0.00306	CcSEcCtD
Topotecan—Constipation—Galantamine—Alzheimer's disease	0.00139	0.00306	CcSEcCtD
Topotecan—Malnutrition—Rivastigmine—Alzheimer's disease	0.00137	0.00302	CcSEcCtD
Topotecan—Back pain—Memantine—Alzheimer's disease	0.00136	0.00298	CcSEcCtD
Topotecan—Cough—Donepezil—Alzheimer's disease	0.00135	0.00297	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—CST3—Alzheimer's disease	0.00135	0.0187	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—CHRNB2—Alzheimer's disease	0.00135	0.0187	CbGpPWpGaD
Topotecan—Feeling abnormal—Galantamine—Alzheimer's disease	0.00134	0.00295	CcSEcCtD
Topotecan—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00133	0.00293	CcSEcCtD
Topotecan—Back pain—Rivastigmine—Alzheimer's disease	0.00133	0.00292	CcSEcCtD
Topotecan—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00132	0.0029	CcSEcCtD
Topotecan—Chest pain—Donepezil—Alzheimer's disease	0.00132	0.00289	CcSEcCtD
Topotecan—Myalgia—Donepezil—Alzheimer's disease	0.00132	0.00289	CcSEcCtD
Topotecan—Arthralgia—Donepezil—Alzheimer's disease	0.00132	0.00289	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.00131	0.0182	CbGpPWpGaD
Topotecan—Ill-defined disorder—Memantine—Alzheimer's disease	0.0013	0.00286	CcSEcCtD
Topotecan—Discomfort—Donepezil—Alzheimer's disease	0.0013	0.00286	CcSEcCtD
Topotecan—Anaemia—Memantine—Alzheimer's disease	0.0013	0.00285	CcSEcCtD
Topotecan—Abdominal pain—Galantamine—Alzheimer's disease	0.00129	0.00283	CcSEcCtD
Topotecan—Body temperature increased—Galantamine—Alzheimer's disease	0.00129	0.00283	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.00129	0.0179	CbGpPWpGaD
Topotecan—TOP1—Caspase Cascade in Apoptosis—BCL2—Alzheimer's disease	0.00128	0.0178	CbGpPWpGaD
Topotecan—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00128	0.0028	CcSEcCtD
Topotecan—Anaemia—Rivastigmine—Alzheimer's disease	0.00127	0.00279	CcSEcCtD
Topotecan—Malaise—Memantine—Alzheimer's disease	0.00127	0.00278	CcSEcCtD
Topotecan—Leukopenia—Memantine—Alzheimer's disease	0.00126	0.00276	CcSEcCtD
Topotecan—Infection—Donepezil—Alzheimer's disease	0.00126	0.00276	CcSEcCtD
Topotecan—Malaise—Rivastigmine—Alzheimer's disease	0.00124	0.00272	CcSEcCtD
Topotecan—Nervous system disorder—Donepezil—Alzheimer's disease	0.00124	0.00272	CcSEcCtD
Topotecan—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00124	0.00272	CcSEcCtD
Topotecan—Cough—Memantine—Alzheimer's disease	0.00123	0.00269	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—CRH—Alzheimer's disease	0.00122	0.017	CbGpPWpGaD
Topotecan—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00122	0.00268	CcSEcCtD
Topotecan—Anorexia—Donepezil—Alzheimer's disease	0.0012	0.00264	CcSEcCtD
Topotecan—Hypersensitivity—Galantamine—Alzheimer's disease	0.0012	0.00264	CcSEcCtD
Topotecan—Cough—Rivastigmine—Alzheimer's disease	0.0012	0.00263	CcSEcCtD
Topotecan—Arthralgia—Memantine—Alzheimer's disease	0.0012	0.00263	CcSEcCtD
Topotecan—Chest pain—Memantine—Alzheimer's disease	0.0012	0.00263	CcSEcCtD
Topotecan—Myalgia—Memantine—Alzheimer's disease	0.0012	0.00263	CcSEcCtD
Topotecan—Discomfort—Memantine—Alzheimer's disease	0.00118	0.0026	CcSEcCtD
Topotecan—Chest pain—Rivastigmine—Alzheimer's disease	0.00117	0.00257	CcSEcCtD
Topotecan—Arthralgia—Rivastigmine—Alzheimer's disease	0.00117	0.00257	CcSEcCtD
Topotecan—Myalgia—Rivastigmine—Alzheimer's disease	0.00117	0.00257	CcSEcCtD
Topotecan—Asthenia—Galantamine—Alzheimer's disease	0.00117	0.00257	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00116	0.00255	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—NPS—Alzheimer's disease	0.00116	0.0161	CbGpPWpGaD
Topotecan—Discomfort—Rivastigmine—Alzheimer's disease	0.00116	0.00254	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00115	0.00253	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.00114	0.0159	CbGpPWpGaD
Topotecan—Infection—Memantine—Alzheimer's disease	0.00114	0.0025	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—SLC6A4—Alzheimer's disease	0.00114	0.0158	CbGpPWpGaD
Topotecan—Paraesthesia—Donepezil—Alzheimer's disease	0.00113	0.00249	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—CASP3—Alzheimer's disease	0.00113	0.0157	CbGpPWpGaD
Topotecan—Dyspnoea—Donepezil—Alzheimer's disease	0.00113	0.00247	CcSEcCtD
Topotecan—Nervous system disorder—Memantine—Alzheimer's disease	0.00112	0.00247	CcSEcCtD
Topotecan—Thrombocytopenia—Memantine—Alzheimer's disease	0.00112	0.00247	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.00112	0.0156	CbGpPWpGaD
Topotecan—Diarrhoea—Galantamine—Alzheimer's disease	0.00112	0.00245	CcSEcCtD
Topotecan—Infection—Rivastigmine—Alzheimer's disease	0.00111	0.00245	CcSEcCtD
Topotecan—Skin disorder—Memantine—Alzheimer's disease	0.00111	0.00245	CcSEcCtD
Topotecan—Dyspepsia—Donepezil—Alzheimer's disease	0.00111	0.00244	CcSEcCtD
Topotecan—Hyperhidrosis—Memantine—Alzheimer's disease	0.00111	0.00243	CcSEcCtD
Topotecan—ABCB1—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.00111	0.0154	CbGpPWpGaD
Topotecan—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.0011	0.00242	CcSEcCtD
Topotecan—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.0011	0.00241	CcSEcCtD
Topotecan—Decreased appetite—Donepezil—Alzheimer's disease	0.0011	0.00241	CcSEcCtD
Topotecan—Anorexia—Memantine—Alzheimer's disease	0.00109	0.0024	CcSEcCtD
Topotecan—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00109	0.00239	CcSEcCtD
Topotecan—Skin disorder—Rivastigmine—Alzheimer's disease	0.00109	0.00239	CcSEcCtD
Topotecan—Fatigue—Donepezil—Alzheimer's disease	0.00109	0.00239	CcSEcCtD
Topotecan—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00108	0.00238	CcSEcCtD
Topotecan—Pain—Donepezil—Alzheimer's disease	0.00108	0.00237	CcSEcCtD
Topotecan—Constipation—Donepezil—Alzheimer's disease	0.00108	0.00237	CcSEcCtD
Topotecan—Dizziness—Galantamine—Alzheimer's disease	0.00108	0.00237	CcSEcCtD
Topotecan—Anorexia—Rivastigmine—Alzheimer's disease	0.00107	0.00235	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00105	0.00229	CcSEcCtD
Topotecan—Feeling abnormal—Donepezil—Alzheimer's disease	0.00104	0.00229	CcSEcCtD
Topotecan—Vomiting—Galantamine—Alzheimer's disease	0.00104	0.00228	CcSEcCtD
Topotecan—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00103	0.00227	CcSEcCtD
Topotecan—Paraesthesia—Memantine—Alzheimer's disease	0.00103	0.00226	CcSEcCtD
Topotecan—Rash—Galantamine—Alzheimer's disease	0.00103	0.00226	CcSEcCtD
Topotecan—Dermatitis—Galantamine—Alzheimer's disease	0.00103	0.00225	CcSEcCtD
Topotecan—Dyspnoea—Memantine—Alzheimer's disease	0.00102	0.00225	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00102	0.00224	CcSEcCtD
Topotecan—Headache—Galantamine—Alzheimer's disease	0.00102	0.00224	CcSEcCtD
Topotecan—Dyspepsia—Memantine—Alzheimer's disease	0.00101	0.00222	CcSEcCtD
Topotecan—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00101	0.00221	CcSEcCtD
Topotecan—Urticaria—Donepezil—Alzheimer's disease	0.001	0.0022	CcSEcCtD
Topotecan—Dyspnoea—Rivastigmine—Alzheimer's disease	0.001	0.0022	CcSEcCtD
Topotecan—Body temperature increased—Donepezil—Alzheimer's disease	0.000999	0.00219	CcSEcCtD
Topotecan—Abdominal pain—Donepezil—Alzheimer's disease	0.000999	0.00219	CcSEcCtD
Topotecan—Decreased appetite—Memantine—Alzheimer's disease	0.000997	0.00219	CcSEcCtD
Topotecan—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00099	0.00217	CcSEcCtD
Topotecan—Fatigue—Memantine—Alzheimer's disease	0.000989	0.00217	CcSEcCtD
Topotecan—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000988	0.00217	CcSEcCtD
Topotecan—Constipation—Memantine—Alzheimer's disease	0.000981	0.00215	CcSEcCtD
Topotecan—Pain—Memantine—Alzheimer's disease	0.000981	0.00215	CcSEcCtD
Topotecan—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000975	0.00214	CcSEcCtD
Topotecan—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000969	0.00213	CcSEcCtD
Topotecan—Nausea—Galantamine—Alzheimer's disease	0.000968	0.00213	CcSEcCtD
Topotecan—Fatigue—Rivastigmine—Alzheimer's disease	0.000967	0.00212	CcSEcCtD
Topotecan—Constipation—Rivastigmine—Alzheimer's disease	0.00096	0.00211	CcSEcCtD
Topotecan—Pain—Rivastigmine—Alzheimer's disease	0.00096	0.00211	CcSEcCtD
Topotecan—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.00095	0.0132	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—NGFR—Alzheimer's disease	0.000949	0.0132	CbGpPWpGaD
Topotecan—Feeling abnormal—Memantine—Alzheimer's disease	0.000945	0.00208	CcSEcCtD
Topotecan—ABCB1—embryo—Alzheimer's disease	0.000944	0.0255	CbGeAlD
Topotecan—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000938	0.00206	CcSEcCtD
Topotecan—Hypersensitivity—Donepezil—Alzheimer's disease	0.000931	0.00204	CcSEcCtD
Topotecan—ABCG2—Iron uptake and transport—CP—Alzheimer's disease	0.000929	0.0129	CbGpPWpGaD
Topotecan—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000925	0.00203	CcSEcCtD
Topotecan—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000918	0.00201	CcSEcCtD
Topotecan—Urticaria—Memantine—Alzheimer's disease	0.000911	0.002	CcSEcCtD
Topotecan—Body temperature increased—Memantine—Alzheimer's disease	0.000907	0.00199	CcSEcCtD
Topotecan—Abdominal pain—Memantine—Alzheimer's disease	0.000907	0.00199	CcSEcCtD
Topotecan—Asthenia—Donepezil—Alzheimer's disease	0.000906	0.00199	CcSEcCtD
Topotecan—Pruritus—Donepezil—Alzheimer's disease	0.000894	0.00196	CcSEcCtD
Topotecan—Urticaria—Rivastigmine—Alzheimer's disease	0.000891	0.00196	CcSEcCtD
Topotecan—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000887	0.00195	CcSEcCtD
Topotecan—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000887	0.00195	CcSEcCtD
Topotecan—ABCG2—cerebellum—Alzheimer's disease	0.000865	0.0234	CbGeAlD
Topotecan—Diarrhoea—Donepezil—Alzheimer's disease	0.000864	0.0019	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.00086	0.012	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—PPARGC1A—Alzheimer's disease	0.000849	0.0118	CbGpPWpGaD
Topotecan—Hypersensitivity—Memantine—Alzheimer's disease	0.000845	0.00186	CcSEcCtD
Topotecan—Dizziness—Donepezil—Alzheimer's disease	0.000835	0.00183	CcSEcCtD
Topotecan—ABCB1—forebrain—Alzheimer's disease	0.000835	0.0226	CbGeAlD
Topotecan—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000827	0.00182	CcSEcCtD
Topotecan—Asthenia—Memantine—Alzheimer's disease	0.000823	0.00181	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—TNF—Alzheimer's disease	0.000822	0.0114	CbGpPWpGaD
Topotecan—Pruritus—Memantine—Alzheimer's disease	0.000812	0.00178	CcSEcCtD
Topotecan—Asthenia—Rivastigmine—Alzheimer's disease	0.000805	0.00177	CcSEcCtD
Topotecan—ABCG2—Fluoropyrimidine Activity—SMUG1—Alzheimer's disease	0.000804	0.0112	CbGpPWpGaD
Topotecan—Vomiting—Donepezil—Alzheimer's disease	0.000803	0.00176	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.0008	0.0111	CbGpPWpGaD
Topotecan—Rash—Donepezil—Alzheimer's disease	0.000797	0.00175	CcSEcCtD
Topotecan—Dermatitis—Donepezil—Alzheimer's disease	0.000796	0.00175	CcSEcCtD
Topotecan—Pruritus—Rivastigmine—Alzheimer's disease	0.000794	0.00174	CcSEcCtD
Topotecan—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.000792	0.011	CbGpPWpGaD
Topotecan—Headache—Donepezil—Alzheimer's disease	0.000791	0.00174	CcSEcCtD
Topotecan—ABCG2—Iron uptake and transport—TF—Alzheimer's disease	0.00079	0.011	CbGpPWpGaD
Topotecan—Diarrhoea—Memantine—Alzheimer's disease	0.000785	0.00172	CcSEcCtD
Topotecan—ABCB1—telencephalon—Alzheimer's disease	0.000768	0.0207	CbGeAlD
Topotecan—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000768	0.00169	CcSEcCtD
Topotecan—Dizziness—Memantine—Alzheimer's disease	0.000758	0.00167	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—PRKCG—Alzheimer's disease	0.000752	0.0105	CbGpPWpGaD
Topotecan—Nausea—Donepezil—Alzheimer's disease	0.00075	0.00165	CcSEcCtD
Topotecan—Dizziness—Rivastigmine—Alzheimer's disease	0.000742	0.00163	CcSEcCtD
Topotecan—Vomiting—Memantine—Alzheimer's disease	0.000729	0.0016	CcSEcCtD
Topotecan—Rash—Memantine—Alzheimer's disease	0.000723	0.00159	CcSEcCtD
Topotecan—Dermatitis—Memantine—Alzheimer's disease	0.000723	0.00159	CcSEcCtD
Topotecan—Headache—Memantine—Alzheimer's disease	0.000719	0.00158	CcSEcCtD
Topotecan—Vomiting—Rivastigmine—Alzheimer's disease	0.000713	0.00157	CcSEcCtD
Topotecan—Rash—Rivastigmine—Alzheimer's disease	0.000708	0.00155	CcSEcCtD
Topotecan—Dermatitis—Rivastigmine—Alzheimer's disease	0.000707	0.00155	CcSEcCtD
Topotecan—Headache—Rivastigmine—Alzheimer's disease	0.000703	0.00154	CcSEcCtD
Topotecan—ABCG2—brain—Alzheimer's disease	0.000703	0.019	CbGeAlD
Topotecan—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.000682	0.00949	CbGpPWpGaD
Topotecan—Nausea—Memantine—Alzheimer's disease	0.000681	0.0015	CcSEcCtD
Topotecan—Nausea—Rivastigmine—Alzheimer's disease	0.000667	0.00146	CcSEcCtD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—CP—Alzheimer's disease	0.000659	0.00917	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—GAB2—Alzheimer's disease	0.000651	0.00905	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—LEP—Alzheimer's disease	0.000648	0.00902	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.000645	0.00897	CbGpPWpGaD
Topotecan—CYP3A4—nervous system—Alzheimer's disease	0.000641	0.0173	CbGeAlD
Topotecan—CYP3A4—central nervous system—Alzheimer's disease	0.000617	0.0167	CbGeAlD
Topotecan—TOP1—Caspase Cascade in Apoptosis—AKT1—Alzheimer's disease	0.000612	0.00851	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—NOS2—Alzheimer's disease	0.000604	0.0084	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.00058	0.00807	CbGpPWpGaD
Topotecan—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000575	0.008	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—PPARG—Alzheimer's disease	0.000565	0.00785	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—MTHFR—Alzheimer's disease	0.000562	0.00782	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—GSK3B—Alzheimer's disease	0.000561	0.00781	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—TF—Alzheimer's disease	0.000561	0.0078	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	0.000558	0.00776	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—CREB1—Alzheimer's disease	0.000557	0.00775	CbGpPWpGaD
Topotecan—ABCG2—Iron uptake and transport—HMOX1—Alzheimer's disease	0.000552	0.00768	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000549	0.00764	CbGpPWpGaD
Topotecan—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000545	0.00759	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—ENO1—Alzheimer's disease	0.000537	0.00748	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	0.000487	0.00677	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—LRRK2—Alzheimer's disease	0.000479	0.00666	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	0.000463	0.00644	CbGpPWpGaD
Topotecan—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000456	0.00635	CbGpPWpGaD
Topotecan—ABCB1—nervous system—Alzheimer's disease	0.000453	0.0122	CbGeAlD
Topotecan—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000439	0.0061	CbGpPWpGaD
Topotecan—ABCB1—central nervous system—Alzheimer's disease	0.000437	0.0118	CbGeAlD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	0.000429	0.00597	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000427	0.00594	CbGpPWpGaD
Topotecan—ABCB1—cerebellum—Alzheimer's disease	0.000427	0.0115	CbGeAlD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000422	0.00587	CbGpPWpGaD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.00042	0.00584	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	0.000395	0.00549	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—HMOX1—Alzheimer's disease	0.000392	0.00545	CbGpPWpGaD
Topotecan—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.00038	0.00529	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—MAPK8—Alzheimer's disease	0.000379	0.00527	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	0.000364	0.00507	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—CP—Alzheimer's disease	0.000356	0.00496	CbGpPWpGaD
Topotecan—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000355	0.00494	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB2—Alzheimer's disease	0.000352	0.00489	CbGpPWpGaD
Topotecan—ABCB1—brain—Alzheimer's disease	0.000347	0.00936	CbGeAlD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000346	0.00482	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000339	0.00472	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	0.000334	0.00465	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000315	0.00439	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	0.000312	0.00434	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—TF—Alzheimer's disease	0.000303	0.00422	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000302	0.0042	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—LEP—Alzheimer's disease	0.000301	0.00418	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—ENO1—Alzheimer's disease	0.000291	0.00404	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—NOS2—Alzheimer's disease	0.00028	0.0039	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—Alzheimer's disease	0.000276	0.00384	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	0.000275	0.00383	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—TP53—Alzheimer's disease	0.000264	0.00368	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000259	0.0036	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—CREB1—Alzheimer's disease	0.000258	0.00359	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—IL6—Alzheimer's disease	0.000242	0.00337	CbGpPWpGaD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000241	0.00335	CbGpPWpGaD
Topotecan—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000234	0.00326	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	0.000233	0.00323	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—TP53—Alzheimer's disease	0.000213	0.00297	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Alzheimer's disease	0.000212	0.00295	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.00021	0.00291	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000207	0.00287	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000189	0.00264	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000187	0.0026	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.000184	0.00256	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000183	0.00255	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000181	0.00252	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000178	0.00248	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL1A—Alzheimer's disease	0.000172	0.00239	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000163	0.00227	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—LEP—Alzheimer's disease	0.000162	0.00226	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	0.000162	0.00226	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.000161	0.00224	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000157	0.00218	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000154	0.00214	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—NOS2—Alzheimer's disease	0.000151	0.00211	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000149	0.00207	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000148	0.00206	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000144	0.00201	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—DHCR24—Alzheimer's disease	0.000142	0.00197	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—CREB1—Alzheimer's disease	0.00014	0.00194	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.000135	0.00188	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.000133	0.00184	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CA4—Alzheimer's disease	0.00012	0.00167	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.000117	0.00163	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000115	0.00161	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000113	0.00158	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GAPDHS—Alzheimer's disease	0.000113	0.00157	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000112	0.00156	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	0.00011	0.00153	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ATP5A1—Alzheimer's disease	0.000107	0.00149	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	0.000104	0.00144	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PLD3—Alzheimer's disease	0.000102	0.00142	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HSD17B10—Alzheimer's disease	9.81e-05	0.00137	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	9.63e-05	0.00134	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—TF—Alzheimer's disease	9.51e-05	0.00132	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP46A1—Alzheimer's disease	9.45e-05	0.00131	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ND1—Alzheimer's disease	9.12e-05	0.00127	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL1B—Alzheimer's disease	8.97e-05	0.00125	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CASP3—Alzheimer's disease	8.95e-05	0.00125	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	8.84e-05	0.00123	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	8.77e-05	0.00122	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	8.32e-05	0.00116	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	8.23e-05	0.00114	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	8.16e-05	0.00114	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	8.05e-05	0.00112	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—DHCR24—Alzheimer's disease	7.65e-05	0.00106	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	7.6e-05	0.00106	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	6.97e-05	0.00097	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.65e-05	0.000926	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	6.63e-05	0.000922	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	6.51e-05	0.000906	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CA4—Alzheimer's disease	6.51e-05	0.000905	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	6.12e-05	0.000851	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	6.05e-05	0.000841	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	5.97e-05	0.00083	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—TPI1—Alzheimer's disease	5.88e-05	0.000818	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CHAT—Alzheimer's disease	5.88e-05	0.000818	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	5.8e-05	0.000807	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	5.74e-05	0.000798	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MAOB—Alzheimer's disease	5.64e-05	0.000784	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	5.6e-05	0.000779	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PLD3—Alzheimer's disease	5.53e-05	0.00077	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GAPDH—Alzheimer's disease	5.43e-05	0.000755	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	5.31e-05	0.000738	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—A2M—Alzheimer's disease	5.24e-05	0.000729	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	5.14e-05	0.000715	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	5.11e-05	0.00071	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	5.01e-05	0.000697	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ND1—Alzheimer's disease	4.93e-05	0.000686	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	4.76e-05	0.000662	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	4.72e-05	0.000656	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ACHE—Alzheimer's disease	4.56e-05	0.000634	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—INPP5D—Alzheimer's disease	4.51e-05	0.000627	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	4.42e-05	0.000615	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS1—Alzheimer's disease	4.27e-05	0.000594	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ENO1—Alzheimer's disease	4.27e-05	0.000594	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2D6—Alzheimer's disease	4.19e-05	0.000583	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	4.06e-05	0.000565	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CA4—Alzheimer's disease	4.01e-05	0.000558	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—BCHE—Alzheimer's disease	3.97e-05	0.000552	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	3.77e-05	0.000524	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	3.75e-05	0.000521	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PLCB1—Alzheimer's disease	3.75e-05	0.000521	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCA1—Alzheimer's disease	3.63e-05	0.000505	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	3.6e-05	0.0005	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	3.57e-05	0.000497	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	3.44e-05	0.000479	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PLD3—Alzheimer's disease	3.41e-05	0.000474	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	3.27e-05	0.000455	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	3.21e-05	0.000447	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TPI1—Alzheimer's disease	3.18e-05	0.000442	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CHAT—Alzheimer's disease	3.18e-05	0.000442	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.15e-05	0.000438	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPARGC1A—Alzheimer's disease	3.13e-05	0.000435	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HMOX1—Alzheimer's disease	3.12e-05	0.000433	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MAOB—Alzheimer's disease	3.05e-05	0.000424	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.04e-05	0.000423	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GAPDH—Alzheimer's disease	2.93e-05	0.000408	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LPL—Alzheimer's disease	2.85e-05	0.000396	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—A2M—Alzheimer's disease	2.83e-05	0.000394	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.83e-05	0.000394	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MTHFR—Alzheimer's disease	2.57e-05	0.000357	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ACHE—Alzheimer's disease	2.46e-05	0.000343	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—INPP5D—Alzheimer's disease	2.44e-05	0.000339	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CALM1—Alzheimer's disease	2.4e-05	0.000333	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.39e-05	0.000333	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOE—Alzheimer's disease	2.39e-05	0.000332	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CAV1—Alzheimer's disease	2.37e-05	0.000329	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS1—Alzheimer's disease	2.31e-05	0.000321	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ENO1—Alzheimer's disease	2.31e-05	0.000321	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	2.26e-05	0.000315	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—BCHE—Alzheimer's disease	2.15e-05	0.000299	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPARG—Alzheimer's disease	2.08e-05	0.000289	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—INS—Alzheimer's disease	2.04e-05	0.000284	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PLCB1—Alzheimer's disease	2.03e-05	0.000282	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCA1—Alzheimer's disease	1.96e-05	0.000273	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.96e-05	0.000272	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.96e-05	0.000272	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.88e-05	0.000261	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.81e-05	0.000251	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NOS3—Alzheimer's disease	1.79e-05	0.000249	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.75e-05	0.000243	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	1.69e-05	0.000235	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HMOX1—Alzheimer's disease	1.68e-05	0.000234	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS2—Alzheimer's disease	1.64e-05	0.000228	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LPL—Alzheimer's disease	1.54e-05	0.000214	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.52e-05	0.000211	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.5e-05	0.000209	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.42e-05	0.000198	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.42e-05	0.000198	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.4e-05	0.000194	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.39e-05	0.000193	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.32e-05	0.000184	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.3e-05	0.00018	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOE—Alzheimer's disease	1.29e-05	0.00018	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.28e-05	0.000178	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.25e-05	0.000174	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.21e-05	0.000168	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.12e-05	0.000156	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—INS—Alzheimer's disease	1.1e-05	0.000153	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.04e-05	0.000145	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.04e-05	0.000144	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NOS3—Alzheimer's disease	9.68e-06	0.000135	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LPL—Alzheimer's disease	9.49e-06	0.000132	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS2—Alzheimer's disease	8.85e-06	0.000123	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	8.55e-06	0.000119	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKT1—Alzheimer's disease	8.23e-06	0.000114	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CALM1—Alzheimer's disease	7.99e-06	0.000111	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOE—Alzheimer's disease	7.96e-06	0.000111	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CAV1—Alzheimer's disease	7.88e-06	0.00011	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPARG—Alzheimer's disease	6.93e-06	9.64e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—INS—Alzheimer's disease	6.8e-06	9.46e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NOS3—Alzheimer's disease	5.96e-06	8.29e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	5.45e-06	7.58e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKT1—Alzheimer's disease	4.45e-06	6.19e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.74e-06	3.81e-05	CbGpPWpGaD
